Inhaled COVID-19 vaccine successful in animal study
One dose of an inhaled infectious-disease infectious-disease showed success in animal studies, researchers say, possibly opening the door for another option that’s easier to administer than the traditional needle shots. The vaccine, dubbed PIV5, was developed using a platform previously used for influenza vaccines and targets mucosal cells that line the nasal passages and airways. …